AAAAAA
Results:
1-12
|
Results: 12
Authors:
KYRLE PA
MANNHALTER C
BEGUIN S
STUMPFLEN A
HIRSCHL M
WELTERMANN A
STAIN M
BRENNER B
SPEISER W
PABINGER I
LECHNER K
EICHINGER S
Citation: Pa. Kyrle et al., CLINICAL-STUDIES AND THROMBIN GENERATION IN PATIENTS HOMOZYGOUS OR HETEROZYGOUS FOR THE G20210A MUTATION IN THE PROTHROMBIN GENE, Arteriosclerosis, thrombosis, and vascular biology, 18(8), 1998, pp. 1287-1291
Authors:
WELTERMANN A
EICHINGER S
KYRLE PA
Citation: A. Weltermann et al., A NOVEL IMMUNOASSAY FOR THE QUANTIFICATION OF HUMAN TISSUE FACTOR-BINDING TO ACTIVATED FACTOR-VII, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 177-182
Authors:
WELTERMANN A
PABINGER I
GEISSLER K
JAGER U
GISSLINGER H
KNOBL P
EICHINGER S
KYRLE PA
VALENT P
SPEISER W
SCHWARZINGER I
MANNHALTER C
LECHNER K
Citation: A. Weltermann et al., HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS, Leukemia, 12(8), 1998, pp. 1182-1186
Authors:
WELTERMANN A
MITTERBAUER GJ
MITTERBAUER M
HATTEY E
SPEISER W
GISSLINGER H
KNOBL P
EICHINGER S
Citation: A. Weltermann et al., DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT), Wiener Klinische Wochenschrift, 110(2), 1998, pp. 53-57
Authors:
WELTERMANN A
KYRLE PA
EICHINGER S
Citation: A. Weltermann et al., QUANTIFICATION OF HUMAN TISSUE FACTOR (TF) BINDING TO RECOMBINANT FACTOR VIIA (RVIIA), Thrombosis and haemostasis, 1997, pp. 1649-1649
Authors:
EICHINGER S
BRENNER B
PHILIPP K
PUTZ M
SCHUCHTER K
BAUER K
KITTL E
KAIDER A
WELTERMANN A
LECHNER K
KYRLE PA
Citation: S. Eichinger et al., MARKED COAGULATION ACTIVATION DURING PREGNANCY WITHOUT EVIDENCE OF VENOUS THROMBOEMBOLISM (VTE), Thrombosis and haemostasis, 1997, pp. 2475-2475
Authors:
KYRLE PA
STUMPFLEN A
HIRSCHL M
BIALONCZYK C
HERKNER K
SPEISER W
WELTERMANN A
KAIDER A
PABINGER I
LECHNER K
EICHINGER S
Citation: Pa. Kyrle et al., LEVELS OF PROTHROMBIN FRAGMENT F1+2 IN PATIENTS WITH HYPERHOMOCYSTEINEMIA AND A HISTORY OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 78(5), 1997, pp. 1327-1331
Authors:
WOLZT M
EDER M
WELTERMANN A
ENTLICHER J
EICHLER HG
KYRLE PA
Citation: M. Wolzt et al., COMPARISON OF THE EFFECTS OF DIFFERENT LOW-MOLECULAR-WEIGHT HEPARINS ON THE HEMOSTATIC SYSTEM ACTIVATION IN-VIVO IN MAN, Thrombosis and haemostasis, 78(2), 1997, pp. 876-879
Authors:
KYRLE PA
EICHINGER S
PABINGER I
STUMPFLEN A
HIRSCHL M
BIALONCZYK C
SCHNEIDER B
MANNHALTER C
MELICHART M
TRAXLER G
WELTERMANN A
SPEISER W
LECHNER K
Citation: Pa. Kyrle et al., PROTHROMBIN FRAGMENT F1+2 IS NOT PREDICTIVE FOR RECURRENT VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 77(5), 1997, pp. 829-833
Authors:
KYRLE PA
BROCKMEIER J
WELTERMANN A
EICHINGER S
SPEISER W
LECHNER K
EICHLER HG
Citation: Pa. Kyrle et al., INHIBITION RATHER THAN ENHANCEMENT OF HEMOSTATIC SYSTEM ACTIVATION DURING INITIATION OF ORAL ANTICOAGULANT TREATMENT, Thrombosis and haemostasis, 77(4), 1997, pp. 685-689
LABORATORY STUDIES ON THE RELIABILITY OF A COMMERCIAL IMMUNOASSAY FORTHROMBIN-ANTITHROMBIN COMPLEXES
Authors:
WELTERMANN A
KYRLE PA
Citation: A. Weltermann et Pa. Kyrle, LABORATORY STUDIES ON THE RELIABILITY OF A COMMERCIAL IMMUNOASSAY FORTHROMBIN-ANTITHROMBIN COMPLEXES, Blood coagulation & fibrinolysis, 7(5), 1996, pp. 580-581
Authors:
WOLZT M
WELTERMANN A
NIESZPAURLOS M
SCHNEIDER B
FASSOLT A
LECHNER K
EICHLER HG
KYRLE PA
Citation: M. Wolzt et al., STUDIES ON THE NEUTRALIZING EFFECTS OF PROTAMINE ON UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN(R)) AT THE SITE OF ACTIVATION OF THE COAGULATION SYSTEM IN MAN, Thrombosis and haemostasis, 73(3), 1995, pp. 439-443
Risultati:
1-12
|